In the STEP 1 semaglutide extension, participants regained about two-thirds of their prior weight loss within one year after withdrawal
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (surpass-3): A randomised, open-label, parallel-group, phase 3 trial
Catalyst Events and Market Watch Significant upcoming catalyst events include the phase [name] readout of Eli Lillys glipron, which will indicate the efficacy of oral GLP-1s, followed by Pfizers glipron and other oral GLP-1s by 2028
Treatment Options: What Works Instead of Patches When it comes to weight loss in midlife, there are effective, evidence-based optionsjust not in the form of over-the-counter patches
33 Although decreases in gastric emptying via GLP-1RAs help prevent overnutrition by decreasing nutrient absorption, there is concern that patients could be at risk of nutrient deficiencies driven by malabsorption from delayed gastric emptying
What Are Retatrutide and Tirzepatide
